Background. Blood lactate is a strong predictor of mortality, and repeated blood lactate assays are recommended during surgery in high-risk patients. We hypothesized that the use of intravascular microdialysis incorporated in a central venous catheter would be interchangeable with the reference blood gas technique to monitor changes in blood lactate. Methods. Microdialysis and central venous blood lactate measurements were recorded simultaneously in high-risk cardiac surgical patients. The correlation between absolute values was determined by linear regression, and the Bland-Altman test for repeated measurements was used to compare bias, precision, and limits of agreement. Changes in lactate measurements were evaluated with a four-quadrant plot and trend interchangeability method (TIM). Results. In the 23 patients analysed, the central venous catheter was used as part of standard care, with no complications. The correlation coefficient for absolute values (n¼104) was 0.96 (P<0.0001). The bias, precision, and limits of agreement were À0.19, 0.51, and À1.20 to 0.82 mmol litre
The concept of lactate clearance was developed >15 yr ago. Defined as the percentage decrease in blood lactate from emergency department admission to 6 h after admission, it has been described as an independent predictor of mortality. 1 A multicentre randomized controlled study subsequently showed that lactate goal-directed therapy with lactate monitoring decreased hospital mortality in unselected critically ill patients. 2 Recently, two studies have confirmed that bedside lactate monitoring can improve clinical outcomes in septic patients. 3 4 Similar results have been reported for critically ill surgical patients. 5 6 In particular, intraoperative changes in blood lactate have been reported to be associated with postoperative outcome in cardiac surgery patients. 7 8 Repeated blood lactate assays are therefore recommended to monitor lactate production and clearance over time during surgery in high-risk patients 9 and during initial resuscitation in septic patients. 10 New technologies that use a central venous catheter combined with a microdialysis method now permit continuous blood lactate monitoring. Two recent studies have reported encouraging results with this device by comparing absolute values (Eirus; Maquet Critical Care, Solna, Sweden), but without the evaluation of trending ability. 11 12 Before considering the more extensive use of this new device for daily practice, its accuracy must be evaluated further in independent studies. The objective of the present study, conducted in selected high-risk cardiac surgical patients, was to compare intravascular microdialysis with the measurement of central venous blood gases as the reference method. We tested the hypothesis that blood lactate changes determined by intravascular microdialysis would be interchangeable with those measured via the reference method.
Methods

Ethics committee approval
After approval by the local Ethics Committee [Reference A14-D36-VOL.22, CPP Nord Ouest III, Caen University Hospital, France (Chairman: Dr C. Gourio) on October 21, 2014 ], all consecutive adult patients admitted from January 2015 to July 2015 who were undergoing high-risk cardiac surgery were eligible for inclusion in the study. As data were collected during the administration of routine care according to standard procedures currently used in our institution, the need for written informed consent was waived. However, preoperative verbal consent was obtained from all study participants. The study was registered at ClinicalTrials.gov (NCT02296593), and the study methodology complied with the STROBE Statement 13 and GRRAS guidelines. 14 
Study population
High-risk cardiac surgical patients (i.e. those with an elevated risk of elevated blood lactate) were included before surgery if they had a left ventricular ejection fraction of <30% or were undergoing high-risk cardiac surgery (aortic dissection, double valve replacement, left ventricular assist device, left ventriculoplasty, or endocarditis) with cardiopulmonary bypass (CPB), or both. An appointed anaesthetist (C.G.) acquired all data. Patients without high surgical risk, off-pump cardiac surgery (predictable short operating time), or for whom the investigator was not available were not included. Patients with central venous catheter misplacement (not positioned with the tip in the superior vena cava above the right atrium confirmed by echocardiography) were excluded from the study. As recommended by the manufacturer, blood lactate values >10 mmol litre À1 were not analysed, as the Eirus device V2.0 cannot provide accurate values in this range (the monitor simply displays '>10 mmol.l À1 ').
Study procedure
All patients underwent general anaesthesia with propofol and remifentanil to maintain a bispectral index between 40 and 60 during surgery. Patients' lungs were ventilated using a volumecontrolled method. After the induction of anaesthesia, a radial arterial catheter and a right jugular central venous catheter (CVC) with an integrated microdialysis function (Eirus; Maquet Critical Care AB, Solna, Sweden) were placed using ultrasound guidance in all patients. The CVC was then connected to a dedicated monitor (Eirus V2.0; Maquet Critical Care AB) via a specific microdialysis sensor, which converts biochemical data into numerical data (lactate Eirus ). This specific five-lumen central venous catheter used two dedicated lumens for the microdialysis system and three lumens for usual drug administration. After the automatic rinsing of the system with sodium chloride 0.9% solution, venous blood lactate measurements were calibrated with a blood sample obtained from the central venous
Editor's key points
• Blood lactate monitoring is increasingly used, and changes in lactate correlate with outcome in critical illness, sepsis, and after cardiac surgery.
• Devices using intravascular microdialysis to monitor lactate continuously are now available, but their accuracy is not fully established.
• In this study of high-risk cardiac surgical patients, there was good correlation between absolute values and changes in lactate measured using intravascular dialysis and a standard blood gas analyser.
• However, trend interchangeability analysis showed that the majority of the changes in lactate were not interpretable or not interchangeable.
• Further data are needed, but clinicians should be aware of the limitations of intravascular dialysis for monitoring lactate.
catheter (lactate ref ) with a blood gas analyser (ABL 800 Flex; Radiometer Medical, Copenhagen, Denmark). Continuous blood lactate values were then displayed on the monitor with a 5 min delay (corresponding to the transit time for microdialysis fluid from the microdialysis membrane to the microdialysis sensor). Cardiopulmonary bypass with a heart-lung machine (Stockert Sorin CP5, Munich, Germany) was performed at a target blood flow >2.4 litres min À1 m À2 , and mean arterial pressure was maintained at >60 mm Hg initially by increasing pump flow, or if blood pressure did not improve, by bolus administration of phenylephrine or norepinephrine. During cardiopulmonary bypass, normothermia (bladder temperature >36 C) was maintained. Cardioprotection was with anterograde (via the aortic root or coronary ostia) or retrograde (coronary sinus) cold blood cardioplegia, or both, depending on the procedure. Intraoperative haemofiltration was not performed in any of the patients in the study.
Data processing
Patient characteristics (sex, age, height, weight, preoperative left ventricular ejection fraction, history of systemic hypertension, diabetes mellitus, chronic obstructive pulmonary disease, and EuroSCORE) 15 and type of surgery were recorded.
One hour after calibration, the blood lactate measurement displayed on the monitor was recorded by a dedicated investigator (C.G.) 5 min after each central venous sample to accommodate the microdialysis time lag, and measurements were repeated every 30-60 min during surgery. Blood samples were analysed immediately with a blood gas analyser located adjacent to the operating room. The presence or the absence of CPB was recorded for each measurement. The number of measurements depended on the surgical procedure and differed for each patient.
The repeatability of the blood gas analyser, previously determined on 30 sets of measurements for one sample and based on the mean of three different samples, was calculated to be 3%.
Statistical analysis
Data are expressed as mean (SD) or median (interquartile range) for non-normally distributed variables (Kolmogorov-Smirnov test) or number (percentage), as appropriate.
Correlations between absolute values of lactate ref and lactate Eirus during surgery were determined by linear regression, with the calculation of the corresponding correlation coefficient. The bias, precision (SD of bias), and limits of agreement [(bias (1.96 SD)] were evaluated using multiple observations per subject. 16 Changes in blood lactate measurements were evaluated via the four-quadrant plot method 17 and the trend interchangeability method (TIM), as recently described. 18 Briefly, this new method was designed to define objectively the interchangeability of each change of a variable. Using the repeatability of the reference method, each change can be classified as uninterpretable or interpretable, and then as interchangeable, in the grey zone, or non-interchangeable. An interchangeability rate can then be calculated by the number of interchangeable changes divided by the total number of interpretable changes. 18 
Results
Thirty-nine patients met the eligibility criteria, but 15 were excluded because the investigator was unavailable, and one patient was excluded because of catheter misplacement ( Fig. 1 and Table 1 ). For the remaining 23 patients, the CVC was used for standard perioperative care. After CVC removal, no blood clotting was observed on the microdialysis membrane, and no CVC-related complications were reported.
A total of 108 pairs of absolute blood lactate values were recorded. Four pairs were higher than 10 mmol litre À1 and were not analysed. The mean value for the remaining pairs (n¼104) was 4. , respectively (Fig. 3) . Eighty pairs of changes in blood lactate measurements were collected, with a mean of 3.5 (1.8) measurements per patient (range, 0-8). The four-quadrant plots (Fig. 5A ) present relative changes of blood lactate values. The calculated concordance rate was 94%. Using the TIM, 23 (29) changes in blood lactate measurements were uninterpretable. Among the remaining 57 (71%) interpretable changes, 18 (32%) were interchangeable, 8 (14%) were in the grey zone, and 31 (54%) were not interchangeable ( Fig. 5A and B) .
Discussion
The main findings of this observational study conducted in high-risk cardiac surgical patients are as follows: (i) absolute blood lactate measurements obtained with the Eirus device were well correlated with those obtained with the reference method, with acceptable agreement; and (ii) although changes in blood lactate measurements as assessed with Eirus and the reference method showed an excellent concordance rate, changes between the two methods were poorly interchangeable with the TIM.
Blood lactate monitoring is very useful in high-risk surgical patients, and it has been described as an accurate marker of occult hypoperfusion and is closely correlated with postoperative morbidity. 6 Likewise, a blood lactate measurement at the time of admission to the intensive care unit has a prognostic value, as mortality may be increased even for values within the usual normal range (>0.75 mmol litre À1 ). 5 Moreover, some markers of tissue perfusion may be in the normal range (such as central venous saturation), despite the presence of tissue hypoperfusion, which emphasizes the importance of multimodal monitoring by blood lactate measurements. 19 Elevated blood lactate can be the result of either anaerobic metabolism, which reflects the tissue oxygen debt (inadequate microvascular oxygen supply), or other metabolic processes (increased glycolysis depending on factors other than hypoxia as a result of metabolic changes, impaired lactate clearance, or toxic causes). 20 This point is important because the treatment of hyperlactataemia should relate to its pathophysiology. 20 In patients with hypoxic hyperlactataemia, an increased lactate concentration should be seen as an indication to improve organ perfusion (fluid loading, vasopressors, and inotropic agents as needed). In contrast, in patients with non-hypoxic hyperlactataemia, the therapeutics differ greatly (decrease epinephrine if hyperadrenergic stimulation, stop medication if excessive metformin or albuterol use, treatment of liver dysfunction, etc.).
20
A previous validation study in humans compared static blood lactate values obtained via the microdialysis method and the reference arterial blood gases method 11 and reported similar results in terms of the correlation coefficient, but the present study presented wider bias and limits of agreement, probably because of the broader range of lactate values, between 0.4 and 8.7 mmol litre
À1
. Another recent study reported an excellent correlation for blood lactate values between the microdialysis method and arterial blood gases in high-risk cardiac surgery patients. 12 Interestingly, similar results were obtained in the operating room and in the postoperative intensive care unit. 12 However, previous studies did not assess changes in blood lactate measurements. The present study presents results in terms of changes in blood lactate measurements with microdialysis compared with the reference method, as changes in blood lactate measurements are more informative about the efficacy of treatment than static values. In the hypoxic theory of hyperlactataemia, early lactate clearance is strongly associated with improved outcome in patients with severe sepsis and septic shock.
1 Repeated blood lactate measurements are recommended to monitor lactate clearance for septic patients 10 and during surgery in highrisk patients. 9 In the present study, we used the TIM, a new method to study the changes recorded by two techniques objectively and specifically. 18 The TIM complies with the GRRAS guidelines and appears to be more rigorous than previously published methods. 18 By analysing the repeatability of the refer- zone, or interchangeable. An interchangeability rate (number of interchangeable changes divided by the total number of interpretable changes) can then be calculated. The TIM has also been described as a plug-and-play method by using free tools available online. 18 In contrast with the four-quadrant plots method, the TIM showed that microdialysis was interchangeable in onethird of interpretable blood lactate changes, which would appear to be insufficient for clinical practice. One explanation could be that the device was not sufficiently precise to follow the lactate clearance and cannot be used at bedside. Another explanation could be related to specific technical limitations of the present study. Indeed, the validity of the present study is limited by the intraoperative period, and some specific factors of this type of surgery, such as CPB, mechanical contact of the 
Analysed changes n=80
Interpretable n= 57 (71)
Grey zone n =8 (14) Not interchangeable n =31 (54) microdialysis catheter and CPB canula, priming, reperfusion, or hypothermia, could influence lactate measurements. Some limitations of this study should be discussed. First, the study population consisted of selected high-risk cardiac surgical patients. Other studies must be conducted during other types of surgery to assess the clinical value of microdialysis before recommending more extensive use of this technique. In particular, high-risk septic patients should be evaluated during the perioperative period. Second, we used venous blood for reference blood lactate measurements. The investigators considered this approach to be more reliable, as the central venous catheter was inserted in the internal jugular vein, and the comparison between microdialysis values and arterial blood samples could be considered to constitute a bias, which would decrease the internal validity of the study. Moreover, arterial and central venous blood lactate have been reported to be interchangeable. 21 Third, high blood lactate measurements (>10 mmol litre
À1
) were not evaluated in this study, although the assessment of high blood lactate concentrations could be more clinically relevant. Last, phase 3 clinical utility/outcome studies are required to evaluate lactate Eirus monitoring and validate its clinical value for early goal-directed therapy.
In conclusion, microdialysis with an invasive central venous catheter during the intraoperative period for high-risk cardiac surgery appears to provide reliable absolute blood lactate values. However, only one-third of changes in blood lactate measurements were interchangeable with the reference method, which means that this method must be used with caution. Further studies are mandatory before recommending this new device in routine clinical practice for high-risk surgical patients or critically ill patients.
